MSN Laboratories Pvt. Ltd. can’t reopen disputes resolved in earlier litigation over the scope, validity, and infringement of ...

Vivian has entered into a distribution agreement with worldwide R&D pharmaceutical company Novartis Pharma Services AG, a move that continues to reflect Vivian's established reputation as a ...

New medications are the first to benefit from initiative that aims to speed up access to oncology breakthroughs ...

In recent decades, merger and acquisition activity has sent long-standing Michigan businesses' leadership out-of-state and ...

The global dry eye syndrome treatment market is projected to record high single-digit growth through 2027. Market expansion is primarily driven by the rising prevalence of dry eye disease, rapid ...

Vas Narasimhan, CEO of Novartis, joins 'Money Movers' to discuss U.S. drug pricing, healthcare, and more.

Novartis CEO Vas Narasimhan urges shifting the U.S. healthcare debate to cutting patient out-of-pocket costs, warns on PBMs/hospitals, and EU ...

The FDA has granted breakthrough therapy designation to Novartis’ ianalumab for Sjögren’s disease, according to a press release from the manufacturer.In its statement, Novartis said it plans to submit ...

The pharmaceutical industry is being reshaped by new scientific, operational, and global demands. The CEO of Novartis shares ...

Access to treatment for leprosy is essential to global efforts to eliminate leprosy, says the World Health Organization (WHO) ahead of World Leprosy Day, to be observed on 25 January. Leprosy is an ...

In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its ...

Debt Management: Incyte's debt-to-equity ratio is below the industry average. With a ratio of 0.01, the company relies less ...